{"transactions":[{"id":945489,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:21:56.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":5.65,"exercise_date":"2027-01-02","expiration_date":"2036-01-02","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-005015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000119312526005015/ownership.xml","form_type":"4"}},{"id":1245084,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T02:30:08.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.97,"expiration_date":"2035-02-25","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-027255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025027255/ownership.xml","form_type":"4"}},{"id":1313151,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-04T02:30:21.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":5.73,"exercise_date":"2026-01-01","expiration_date":"2035-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-001569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000095017025001569/ownership.xml","form_type":"4"}},{"id":1593413,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-03-06T01:00:30.000Z","date":"2023-08-22","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.62,"value":3620.0,"ownership":{"direct":false,"nature":"By Spouse IRA"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. The actual purchase prices range from $3.59 to $3.63 per share. The Reporting Person will supply the SEC, the Issuer, or a security holder of the Issuer, with full information regarding the number of shares at each price upon request."}],"balance_after":17479,"source":{"system":"sec-edgar","filing":"0001493152-24-008916","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224008916/ownership.xml","form_type":"4"}},{"id":1674903,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-19T23:30:22.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to continuous service, 100% of the option will vest on the first anniversary of the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":7.41,"exercise_date":"2025-01-01","expiration_date":"2034-01-01","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-003108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315224003108/ownership.xml","form_type":"4"}},{"id":2065267,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"6% Convertible Note","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"price":0,"reported_value":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."},{"field":"reported_value","element":"transactionTotalValue","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum."}],"balance_after":6479,"derivative":{"exercise_price":4,"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":6479},"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2065266,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to Purchase Common Stock","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering (\"IPO\") at a combined purchase price $5.00 per share and accompanying warrant."}],"balance_after":9479,"derivative":{"exercise_price":7.5,"exercise_date":"2023-01-03","expiration_date":"2025-01-03","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2065265,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":6479,"price":4,"value":25916.0,"ownership":{"direct":true},"balance_after":16479,"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}},{"id":2065264,"issuer":{"id":6727,"kind":"organization","name":"Coya Therapeutics, Inc."},"owners":[{"id":69924,"kind":"person","name":"Lee Ann","position":1,"cik":"0001953080","reported_name":"Lee Ann","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-01-04T13:30:27.000Z","date":"2023-01-03","kind":"purchase","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering (\"IPO\") at a combined purchase price $5.00 per share and accompanying warrant."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001493152-23-000226","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1835022/000149315223000226/ownership.xml","form_type":"4"}}]}